150 related articles for article (PubMed ID: 30910845)
1. Polymorphisms in
Hu A; Li J; Ruan S; Fan Y; Liao Y
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30910845
[No Abstract] [Full Text] [Related]
2. A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer.
Ma F; Ding X; Fan Y; Ying J; Zheng S; Lu N; Xu B
PLoS One; 2014; 9(11):e112765. PubMed ID: 25393310
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in
Liao Y; Liao Y; Li J; Li J; Fan Y; Xu B
Cancer Manag Res; 2018; 10():3801-3808. PubMed ID: 30288111
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms of autophagy-related gene 5 (ATG5) rs473543 predict different disease-free survivals of triple-negative breast cancer patients receiving anthracycline- and/or taxane-based adjuvant chemotherapy.
Li M; Ma F; Wang J; Li Q; Zhang P; Yuan P; Luo Y; Cai R; Fan Y; Chen S; Li Q; Xu B
Chin J Cancer; 2018 Jan; 37(1):4. PubMed ID: 29382381
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in PARP1 predict disease-free survival of triple-negative breast cancer patients treated with anthracycline/taxane based adjuvant chemotherapy.
Liao Y; Liao Y; Li J; Xiong J; Fan Y
Sci Rep; 2020 Apr; 10(1):7349. PubMed ID: 32355298
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the CLDN1 and CLDN7 genes are related to differentiation and tumor stage in colon carcinoma.
Hahn-Strömberg V; Askari S; Befekadu R; Matthiessen P; Karlsson S; Nilsson TK
APMIS; 2014 Jul; 122(7):636-42. PubMed ID: 24479816
[TBL] [Abstract][Full Text] [Related]
7. Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
Bonsang-Kitzis H; Chaltier L; Belin L; Savignoni A; Rouzier R; Sablin MP; Lerebours F; Bidard FC; Cottu P; Sastre-Garau X; Laé M; Pierga JY; Reyal F
PLoS One; 2015; 10(12):e0144359. PubMed ID: 26684197
[TBL] [Abstract][Full Text] [Related]
8. A single-nucleotide polymorphism in the 3'-UTR region of the adipocyte fatty acid binding protein 4 gene is associated with prognosis of triple-negative breast cancer.
Wang W; Yuan P; Yu D; Du F; Zhu A; Li Q; Zhang P; Lin D; Xu B
Oncotarget; 2016 Apr; 7(14):18984-98. PubMed ID: 26959740
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of miR-34 rs4938723 T > C polymorphism in triple negative breast cancer patients.
Tsiakou A; Zagouri F; Zografos E; Samelis G; Gazouli M; Kalapanida D; Giannos A; Marinopoulos S; Dimitrakakis K; Lazaris C A; Rigopoulos D; Zografos G
Clin Biochem; 2019 Jun; 68():9-14. PubMed ID: 30935968
[TBL] [Abstract][Full Text] [Related]
10. Single Nucleotide Polymorphisms (SNPs) of RAD51-G172T and XRCC2-41657C/T Homologous Recombination Repair Genes and the Risk of Triple- Negative Breast Cancer in Polish Women.
Michalska MM; Samulak D; Romanowicz H; Smolarz B
Pathol Oncol Res; 2015 Sep; 21(4):935-40. PubMed ID: 25743260
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 cases.
Zhang Y; Dai J; McNamara KM; Bai B; Shi M; Chan MS; Liu M; Sasano H; Wang X; Li X; Liu L; Ma Y; Cao S; Xing Y; Zhao B; Song Y; Wang L
BMC Cancer; 2015 Oct; 15():699. PubMed ID: 26472563
[TBL] [Abstract][Full Text] [Related]
12. Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients.
Urru SAM; Gallus S; Bosetti C; Moi T; Medda R; Sollai E; Murgia A; Sanges F; Pira G; Manca A; Palmas D; Floris M; Asunis AM; Atzori F; Carru C; D'Incalci M; Ghiani M; Marras V; Onnis D; Santona MC; Sarobba G; Valle E; Canu L; Cossu S; Bulfone A; Rocca PC; De Miglio MR; Orrù S
BMC Cancer; 2018 Jan; 18(1):56. PubMed ID: 29310602
[TBL] [Abstract][Full Text] [Related]
13. High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients.
Rashid MU; Muhammad N; Bajwa S; Faisal S; Tahseen M; Bermejo JL; Amin A; Loya A; Hamann U
BMC Cancer; 2016 Aug; 16(1):673. PubMed ID: 27553291
[TBL] [Abstract][Full Text] [Related]
14. The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion.
Bogan D; Meile L; El Bastawisy A; Yousef HF; Zekri AN; Bahnassy AA; ElShamy WM
BMC Cancer; 2017 May; 17(1):329. PubMed ID: 28499366
[TBL] [Abstract][Full Text] [Related]
15. A functional BRCA1 coding sequence genetic variant contributes to prognosis of triple-negative breast cancer, especially after radiotherapy.
Shi M; Ma F; Liu J; Xing H; Zhu H; Yu J; Yang M
Breast Cancer Res Treat; 2017 Nov; 166(1):109-116. PubMed ID: 28744749
[TBL] [Abstract][Full Text] [Related]
16. Association of IL-1β gene polymorphisms rs1143627, rs1799916, and rs16944 with altered risk of triple-negative breast cancer.
Sghaier I; Sheridan JM; Daldoul A; El-Ghali RM; Al-Awadi AM; Habel AF; Aimagambetova G; Almawi WY
Cytokine; 2024 Aug; 180():156659. PubMed ID: 38781872
[TBL] [Abstract][Full Text] [Related]
17. CYPOR is a novel and independent prognostic biomarker of recurrence-free survival in triple-negative breast cancer patients.
Pedersen MH; Hood BL; Ehmsen S; Beck HC; Conrads TP; Bak M; Ditzel HJ; Leth-Larsen R
Int J Cancer; 2019 Feb; 144(3):631-640. PubMed ID: 30110125
[TBL] [Abstract][Full Text] [Related]
18. Genetic Association of CYP1B1 4326 C>G Polymorphism with Disease-Free Survival in TNBC Patients Undergoing TAC Chemotherapy Regimen.
Abdul Aziz AA; Md Salleh MS; Yahya MM; Zakaria AD; Ankathil R
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1319-1324. PubMed ID: 33906328
[TBL] [Abstract][Full Text] [Related]
19. Outcome of triple negative breast cancer: comparison of sporadic and BRCA1-associated cancers.
Tung N; Gaughan E; Hacker MR; Lee LJ; Alexander B; Poles E; Schnitt SJ; Garber JE
Breast Cancer Res Treat; 2014 Jul; 146(1):175-82. PubMed ID: 24839033
[TBL] [Abstract][Full Text] [Related]
20. Triple-negative breast cancer: An institutional analysis.
Gogia A; Raina V; Deo SV; Shukla NK; Mohanti BK
Indian J Cancer; 2014; 51(2):163-6. PubMed ID: 25104201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
